Pyrazole and 4-methylpyrazole are potent inhibitors of alcohol dehydrogenase, and have been used to block the metabolism of ethanol and for treatment of methanol or ethylene glycol poisoning. Pyrazole, but not 4-methylpyrazole, has been shown to be hepatotoxic. The reasons for these differences are not known. 4-Hydroxypyrazole and 4-hydroxymethylpyrazole are major metabolites found in the urine after in vivo administration of pyrazole or 4-methylpyrazole. The enzyme system(s) responsible for the metabolism of these compounds are not known. Preliminary results show that microsomes from rats treated with pyrazole or 4-methylpyrazole display several properties which are very similar to properties found with microsomes from chronic ethanol-fed rats, suggesting the possibility that pyrazole and 4-methylpyrazole may induce a cytochrome P-450 isozyme which is similar to the ethanol-inducible cytochrome P-450. The overall objective of this application is to study the interaction of pyrazole and 4-methylpyrazole with microsomes and to compare the properties of microsomes from pyrazole- and 4-methylpyrazole-treated rats to those found with microsomes from ethanol-treated rats. Properties to be studied include substrate and alcohol metabolism and specificity, kinetic experimens, substrate binding spectra, content of microsomal enzymes, effect of inhibitors, generation of oxygen radicals and promotion of lipid peroxidation. The metabolism of pyrazole and 4-methylpyrazole by microsomes from control and induced rats will be determined and the metabolites characterized. Attempts to purify the pyrazole- and 4-methylpyrazole-inducible cytochrome P-450 and reconstitution experiments with purified enzymes will be carried out. Some experiments on metabolic consequences of pyrazole and 4-methylpyrazole treatment, and the effects of their metabolites, on hepatocyte function will be performed to evaluate why pyrazole, but not 4-methylpyrazole, is hepatotoxic. It is hoped that these studies will provide important information on the metabolism and on biochemical and pharmacological properties of these important compounds, which are widely used in the alcohol field.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
1R01AA006610-01
Application #
3109822
Study Section
(SRC)
Project Start
1985-06-01
Project End
1989-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Caro, Andres A; Evans, Kerry L; Cederbaum, Arthur I (2009) CYP2E1 overexpression inhibits microsomal Ca2+-ATPase activity in HepG2 cells. Toxicology 255:171-6
Zhuge, Jian; Cederbaum, Arthur I (2009) Inhibition of the mitochondrial permeability transition by cyclosporin A prevents pyrazole plus lipopolysaccharide-induced liver injury in mice. Free Radic Biol Med 46:406-13
Lu, Yongke; Cederbaum, Arthur I (2008) CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44:723-38
Wu, Defeng; Cederbaum, Arthur (2008) Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice. Hepatology 47:1005-17
Jimenez-Lopez, Jose M; Wu, Defeng; Cederbaum, Arthur I (2008) Synergistic toxicity induced by prolonged glutathione depletion and inhibition of nuclear factor-kappaB signaling in liver cells. Toxicol In Vitro 22:106-15
Lu, Yongke; Gong, Pengfei; Cederbaum, Arthur I (2008) Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency. Toxicology 252:9-16
Lu, Yongke; Zhuge, Jian; Wang, Xiaodong et al. (2008) Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 47:1483-94
Lu, Yongke; Cederbaum, Arthur (2007) The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin. Free Radic Biol Med 43:1061-75
Dey, Aparajita; Cederbaum, Arthur I (2007) Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathway. Arch Biochem Biophys 461:275-86
Dey, Aparajita; Cederbaum, Arthur I (2007) Induction of cytochrome P450 2E1 [corrected] promotes liver injury in ob/ob mice. Hepatology 45:1355-65

Showing the most recent 10 out of 108 publications